Microarray analysis in drug discovery and clinical applications.

DNA microarray analyzes genome-wide gene expression patterns and is used in many areas including drug discovery and clinical applications. This chapter summarizes some of these applications such as identification and validation of anti-infective drug target, study mechanisms of drug action and drug metabolism, classification of different types of tumors, and use of molecular signatures for prediction of disease outcome. A step-by-step protocol is provided for sample preparation, sample labeling and purification, hybridization and washing, feature extraction, and data analysis. Important considerations for a successful experiment are also discussed with emphasis on drug discovery and clinical applications. Finally, a clinical study is presented as an example to illustrate how DNA microarray technology can be used to identify gene signatures, and to demonstrate the promise of DNA microarray as a clinical tool.

[1]  G. W. Hatfield,et al.  Global gene expression profiling in Escherichia coli K12. The effects of integration host factor. , 2000, The Journal of biological chemistry.

[2]  P. Johnston,et al.  5-Fluorouracil: mechanisms of action and clinical strategies , 2003, Nature Reviews Cancer.

[3]  T. Houfek,et al.  Transcriptional Regulation of Biomass-degrading Enzymes in the Filamentous Fungus Trichoderma reesei* , 2003, Journal of Biological Chemistry.

[4]  J. Eberwine,et al.  Amplified RNA synthesized from limited quantities of heterogeneous cDNA. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[5]  J. Gordon,et al.  Molecular analysis of commensal host-microbial relationships in the intestine. , 2001, Science.

[6]  Yudong D. He,et al.  A Gene-Expression Signature as a Predictor of Survival in Breast Cancer , 2002 .

[7]  Yudong D. He,et al.  Expression profiling using microarrays fabricated by an ink-jet oligonucleotide synthesizer , 2001, Nature Biotechnology.

[8]  Yidong Chen,et al.  Amine-modified random primers to label probes for DNA microarrays. , 2002 .

[9]  E. Lander,et al.  A molecular signature of metastasis in primary solid tumors , 2003, Nature Genetics.

[10]  Yudong D. He,et al.  Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.

[11]  Klaus Pantel,et al.  Molecular signature associated with bone marrow micrometastasis in human breast cancer. , 2003, Cancer research.

[12]  Ash A. Alizadeh,et al.  Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.

[13]  Jizhong Zhou,et al.  DNA Microarray Analysis of the Hyperthermophilic Archaeon Pyrococcus furiosus: Evidence for a New Type of Sulfur-Reducing Enzyme Complex , 2001, Journal of bacteriology.

[14]  Ronald W. Davis,et al.  Quantitative Monitoring of Gene Expression Patterns with a Complementary DNA Microarray , 1995, Science.

[15]  J. Musser,et al.  Toward a genome-scale understanding of group A Streptococcus pathogenesis. , 2001, Current opinion in microbiology.

[16]  M. Blaser,et al.  Helicobacter pylori strain-specific differences in genetic content, identified by microarray, influence host inflammatory responses. , 2001, The Journal of clinical investigation.